NEUROFIX THERAPEUTICS
neuroFix Therapeutics, LLC, the developer of NFC-1, a first-in-class, non-stimulant metabotropic glutamate receptor (mGluR) neuromodulator entering Phase 2/3 for the treatment of mGluR network mutation positive Attention Deficit Hyperactivity Disorder (mGluR+ ADHD), as well as neuropsychiatric symptoms resulting from a related rare genetic disorder, 22q11.2 Deletion Syndrome (22q11.2 DS).
Similar Organizations
BioNome
Biotechnology Company
Nanorobotics
Innovative Biotech company
River Stone Biotech
Biotech company
More informations about "neuroFix Therapeutics"
neuroFix Therapeutics - Crunchbase Company Profile & Funding
NeuroFix Therapeutics, LLC, the developer of NFC-1, a first-in-class, non-stimulant metabotropic glutamate receptor (mGluR) neuromodulator entering Phase 2/3 for the treatment of mGluR …See details»
neuroFix Therapeutics 2025 Company Profile: Valuation, Investors ...
NeuroFix Therapeutics General Information Description. Developer of therapeutic products. The company develops NFC-1 a non-stimulant metabotropic glutamate receptor for the treatment …See details»
neuroFix, LLC Company Profile | Wayne, PA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for neuroFix, LLC of Wayne, PA. Get the latest business insights from Dun & Bradstreet.See details»
Neurofix Company Profile - Office Locations, Competitors ... - Craft
Neurofix is a biotechnology company providing lipid-based therapies for the treatment of neurological pathologies. Its product NFX88 (2‐hydroxyoleic acid) is a derivative of oleic acid …See details»
neuroFix Therapeutics LLC - Drug pipelines, Patents, Clinical trials ...
Last update 23 Jan 2025. neuroFix Therapeutics LLC. Subsidiary Company |See details»
NeuroFix Therapeutics LLC Company Profile, Financial and
NeuroFix Therapeutics, LLC develops NFC-1, a non-stimulant metabotropic glutamate receptor (mGluR) neuromodulator for the treatment of mGluR network mutation positive Attention …See details»
neuroFix Therapeutics LLC:Company Profile & Technical Research ...
NeuroFix Therapeutics is a company that provides Metabotropic glutamate receptor, Medicine, Mutation and more. neuroFix Therapeutics is headquartered in US PA. neuroFix Therapeutics …See details»
NeuroFix Therapeutics - Ownership and Business Overview - Mergr
Sep 9, 2015 NeuroFix Therapeutics LLC is a developer of NFC-1, a non-stimulant metabotropic glutamate receptor (mGluR) neuromodulator entering Phase 2/3 for the treatment of mGluR …See details»
Neurofix 2025 Company Profile: Valuation, Funding & Investors
Neurofix General Information Description. Developer of lipid-based therapies intended to come up with the treatment of neurological disorders. The company's biotechnology platform provides a …See details»
Neurofix SL - Drug pipelines, Patents, Clinical trials - Synapse
Explore Neurofix SL with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Disease Domain:Nervous System Diseases, Technology Platform:Small molecule drug, …See details»
Neurofix - Crunchbase Company Profile & Funding
Organization. Neurofix . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Neurofix mission is to discover and develop molecules for the treatment of pathologies of the central nervous …See details»
Neurofix Pharma -2022 – Biotechnology company founded by …
Neurofix Pharma presents the successful results of its phase IIA clinical trial to institutions and businessmen in Salamanca 28 de November de 2022 - 08:46 Mañueco visits the offices of …See details»
Consultant - NeuroFix, LLC and Arctic Therapeutics - LinkedIn
Led organization during post 9/11 federalization of work force that required growth from 4,200 employees to 11,000 and a subsequent contraction to 2,200 employees. Annualized revenue …See details»
Neurofix Pharma - Products, Competitors, Financials, Employees ...
Neurofix could raise €7.3 million to make NFX88 a marketable product. Improve the quality of life of patients Neurofix Pharma is a biotechnology company that researches and develops drugs …See details»
Juan Manuel Corchado joins Neurofix Pharma as independent …
Apr 3, 2023 Neurofix Pharma is a biotech company that has developed a pioneering drug capable of alleviating the neuropathic pain suffered by people with paraplegia. Neurofix …See details»
Woodbridge biotech gets FDA ‘orphan’ status for anti-tumor drug
Federal regulators have deemed a Woodbridge biotechnology company’s tumor-fighting therapy an ‘orphan’ drug, making it eligible for financial incentives. AlloMek Therapeutics earned the …See details»
Revive Therapeutics Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Revive Therapeutics Inc of Woodbridge, ON. Get the latest business insights from Dun & Bradstreet.See details»
THE COMPANY – Neurofix Pharma -2022
Neurofix Pharma presents the successful results of its phase IIA clinical trial to institutions and businessmen in Salamanca 28 de November de 2022 - 08:46 Mañueco visits the offices of …See details»
$101M XPRIZE Healthspan Awards First Milestone Winners Drivi
3 days ago A global non-profit organization headquartered in Riyadh with a North American hub and an annual budget of up to $1 billion, Hevolution Foundation plans to open offices in other …See details»
Dr. Dennis K. McBride - Top Scientists
Dec 19, 2024 Looking to the future, he plans to transform medicine through digital therapeutics, enabling doctors to remotely monitor patients and deliver treatments through semi-worn …See details»